Skip to main content
. 2022 Feb 16;37(8):e64. doi: 10.3346/jkms.2022.37.e64

Table 5. Comparison of ipsilateral breast tumor recurrence among breast cancer hypofractionated radiotherapy trials.

Study name (year of publication) START B (2008) Whelan et al.10 (2010) DBCG HYPO (2020) Current study
No. of patients 2,215 1,234 1,882 178
whole breast dose (cGy) 4,000 4,256 4,000 4,240–4,256
whole breast fractions 15 16 15 16
FU period (yr) 5 10 9 2
local failure (IBTR, %) 2.2 6.7 3.3 0
P value 0.21 0.75 0.41 0.37

FU = follow up, IBTR = ipsilateral breast tumor recurrence.